Clinical Trial Update: Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the maximum tolerated dose, safety, and pharmacokinetics of oral paclitaxel in patients with advanced solid tumors; study status indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• paclitaxel (oral) (paclitaxel)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED